Treating liver failure with stem cell-derived liver cells in the future

March 13, 2018, Agency for Science, Technology and Research (A*STAR), Singapore
Treating liver failure with stem cell-derived liver cells in the future
Stem cell-derived liver cells. A*STAR’s Genome Institute of Singapore

A research collaboration between A*STAR's Genome Institute of Singapore (GIS) and Institute of Molecular and Cellular Biology (IMCB), and the Stanford University School of Medicine, has discovered methods to efficiently generate pure liver cells from human stem cells. This could lead to more effective ways of treating liver failure.

The team, led by Dr. Ang Lay Teng and Dr. Bing Lim from GIS, Professor Kyle Loh and Professor Irving Weissman from the Stanford University School of Medicine, and Dr. Chen Qingfeng from IMCB, also successfully grafted the generated liver into mouse models which improved their short-term survival rate.

Liver disease has few treatments and imposes a substantial healthcare and economic burden1. Currently, end-stage liver failure can only be treated by . Due to the scarce supply of liver donations, more than one million patients worldwide die every year while waiting for transplants. To address this problem, the researchers aim to artificially generate large numbers of liver cells from human .

"Embryonic stem cells have the potential to turn into thousands of cell-types in the human body. The key is to understand how to turn them solely into liver cells. Generating these highly-pure liver cells from embryonic stem cells is an important step towards using these cells for cell transplantation," said Dr. Ang Lay Teng, Senior Research Fellow at GIS. She explained, "The process of generating highly-pure liver cells involves a series of steps. As the whole process of liver development is not fully clear, one major challenge we faced was how to precisely control the development of stem cells into liver cells."

"With almost unlimited development potential, embryonic stem cells can be made to develop into any other cell. The stem cell's development is similar to a complex train map. In this case, the generation of liver cells would be our destination. The crux of our research is to identify the six requisite stops and map the path needed for a stem cell to develop into a liver cell," added Professor Kyle Loh, Assistant Professor at the Stanford University School of Medicine.

Dr. Ang continued, "Another major challenge was the difficulty in obtaining liver cells which were derived from human embryonic stem cells. These cells also needed to be capable of regenerating real liver tissue in animal models. However, our stem cell-derived liver cells were able to be successfully grafted into mouse models with liver injuries. This process improved their short-term survival remarkably. With progress, there is potential to eventually treat patients with liver failure in the future."

Dr. Ng Huck Hui, Executive Director of GIS, said, "The ability to generate large quantities of stem-cell derived holds the potential to sustain patients with liver failure while they await a full transplant. This holds great promise for helping to improve patient survival rates and alleviate the burden of on societies."

The research results were published in Cell Reports on 20 February 2018.

Explore further: Team discovers new liver cell for cellular therapy to aid in liver regeneration

More information: 1. Ali A Mokdad et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis, BMC Medicine (2014). DOI: 10.1186/s12916-014-0145-y

Related Stories

Team discovers new liver cell for cellular therapy to aid in liver regeneration

June 6, 2013
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published ...

Team finds a potentially better way to treat liver cancer

October 12, 2017
A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

Tonsil stem cells could someday help repair liver damage without surgery

September 24, 2014
The liver provides critical functions, such as ridding the body of toxins. Its failure can be deadly, and there are few options for fixing it. But scientists now report in the journal ACS Applied Materials & Interfaces a ...

Restoring what's lost: Uncovering how liver tissue regenerates

March 12, 2012
The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal.

Adult stem cells take root in livers and repair damage

May 11, 2011
Johns Hopkins researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.

Recommended for you

Discovery of inner ear function may improve diagnosis of hearing impairment

October 15, 2018
Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

Researchers create a functional salivary gland organoid

October 11, 2018
A research group led by scientists from Showa University and the RIKEN Center for Biosystems Dynamics Research in Japan have, for the first time, succeeded in growing three-dimensional salivary gland tissue that, when implanted ...

Lassa fever vaccine shows promise and reveals new test for immunity

October 11, 2018
Lassa fever belongs to the same class of hemorrhagic fevers as Ebola. Like Ebola, it has been a major health threat in Western Africa, infecting 100,000-300,000 people and killing 5,000 per year. A new vaccine against both ...

Genetically engineered 3-D human muscle transplant in a murine model

October 10, 2018
A growing need for tissues and organs in surgical reconstruction is addressed by the promising field of tissue engineering. For instance, muscle atrophy results from severe traumatic events including deep burns and cancer, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.